Surgery Doctors in Holmes, NY Accepting Medicare
1 Surgery doctors found. Showing 1 - 1
 Dr. Daniel Frank Peters, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 26 Arbor Ct, Holmes, NY 12531 Phone: 845-878-2181 Fax: 845-878-2181 |
News Archive
Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%
Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.
Series of papers highlights challenges with moving African-developed drugs, technology forward
"Africa is struggling to turn local discoveries into drugs and other health care inventions," according to studies published in Science and BMC International Health and Human Rights, Nature News reports (Nordling, 12/12).
Scientists speed healing of bone damage
Blocking a naturally occurring inhibitor of bone formation accelerates healing of skull defects in mice, say researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital. The finding advances the understanding of how the skeleton develops and opens new therapeutic avenues for many of the disorders that are expected to afflict aging baby boomers.
Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
Alzheimer's drug pioneer to be awarded Israel Prize for Medicine
Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.
› Verified 7 days ago